- Home
- CARV vs TLPH Comparison
CARV vs TLPH Comparison
Compare CARV & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- TLPH
- Stock Information
- Founded
- CARV 1948
- TLPH 2005
- Country
- CARV United States
- TLPH United States
- Employees
- CARV N/A
- TLPH N/A
- Industry
- CARV Savings Institutions
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- TLPH Health Care
- Exchange
- CARV Nasdaq
- TLPH Nasdaq
- Market Cap
- CARV 9.6M
- TLPH 11.1M
- IPO Year
- CARV 1994
- TLPH 2011
- Fundamental
- Price
- CARV $2.35
- TLPH $0.52
- Analyst Decision
- CARV
- TLPH Strong Buy
- Analyst Count
- CARV 0
- TLPH 1
- Target Price
- CARV N/A
- TLPH $6.00
- AVG Volume (30 Days)
- CARV 40.8K
- TLPH 3.4M
- Earning Date
- CARV 08-13-2025
- TLPH 08-14-2025
- Dividend Yield
- CARV N/A
- TLPH N/A
- EPS Growth
- CARV N/A
- TLPH N/A
- EPS
- CARV N/A
- TLPH N/A
- Revenue
- CARV $22,032,000.00
- TLPH $27,000.00
- Revenue This Year
- CARV N/A
- TLPH N/A
- Revenue Next Year
- CARV N/A
- TLPH $14,533.26
- P/E Ratio
- CARV N/A
- TLPH N/A
- Revenue Growth
- CARV N/A
- TLPH N/A
- 52 Week Low
- CARV $1.30
- TLPH $0.38
- 52 Week High
- CARV $3.20
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- CARV 68.97
- TLPH 60.27
- Support Level
- CARV $1.61
- TLPH $0.51
- Resistance Level
- CARV $2.56
- TLPH $0.57
- Average True Range (ATR)
- CARV 0.17
- TLPH 0.06
- MACD
- CARV 0.06
- TLPH 0.01
- Stochastic Oscillator
- CARV 77.89
- TLPH 46.54
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.